Amryt Pharma

24 results

Photograph: iStock

Biopharmaceutical firm Amryt has signed a deal with Aegerion Pharmaceuticals to expand its exclusive licence agreement for Lojuxta (lomitapide). The(...)

Michael Carey, East Coast Bakehouse; Anne Heraty, CEO CPL Resources; and Kevin McLoughlin, partner lead for the EY EOY programme. Photograph: EY

The shortlist for the 2018 EY Entrepreneur of the Year (EOY) awards, now in its 21st year in Ireland, has been released with 24 finalists selected to (...)

The company is focused on rare and orphan diseases.

Irish biopharmaceutical firm Amryt Pharma has signed a new distribution agreement, its fifth in recent months. The company, which is focused on rare (...)

Amryt Pharma focuses on rare and orphan diseases.

Irish biopharmaceutical firm Amryt Pharma has announced the appointment of Derval O’Carroll as head of regulatory affairs. Dr Joe Wiley, chief execut(...)

Photograph: iStock

Irish biopharmaceutical firm Amryt Pharma has signed an agreement to distribute its Lojuxta drug in Switzerland. The company, which focuses on rare (...)

Amryt Pharma chief executive Joe Wiley said the company was at “exciting phase” in terms of treatments

Biopharmaceutical company Amryt Pharma is seeking to raise €15 million to fund clinical trials for the treatment of a rare, genetic skin disorder. Th(...)

Amryt Pharma has reported a sharp rise in sales for the six months to the end of June as the company became a commercial pharmaceutical business. Photograph: Getty

Amryt Pharma has reported a sharp rise in sales for the six months to the end of June, as the company became a commercial pharmaceutical group. Sales(...)

Ibec’s CEO Danny McCoy to speak at the Convenience Retailer Summit. Photograph: Nick Bradshaw

Monday Results: Amryt Pharma. Indicators: Irish Exchequer returns (August); Euro zone PPI (July); UK construction PMI (August). Meetings: Busines(...)

AIB’s HQ: the bank breached the €5 level in its seventh day of trading since returning to the main stock market in Dublin

AIB breached the €5 level in its seventh day of trading since returning to the main stock market in Dublin, amid a global surge in banking stocks, wit(...)

Amryt Pharma says it has made substantial progress since its admission to trading on AIM in April 2016. Photograph: iStock

Specialty drug group Amryt Pharma told shareholders Thursday that it had made “substantial progress” since listing on the London’s junior AIM market l(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • Next
  • Last »